Tevogen Bio Holdings Inc.
TVGN
$0.9364
$0.0323.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.91% | -9.77% | -60.51% | 39.11% | -185.78% |
| Total Depreciation and Amortization | 175.90% | 1.84% | 1.77% | 1.70% | 1.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -55.69% | 3.71% | 125.26% | -39.95% | 135.07% |
| Change in Net Operating Assets | -246.68% | 53.30% | 34.79% | -183.58% | 165.41% |
| Cash from Operations | 3.58% | -8.54% | 19.90% | -27.57% | -37.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -30.00% | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -75.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -50.00% | 42.86% | 27.27% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -52.50% | 100.00% | -60.00% | 78.57% | 15.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -286.40% | 166.04% | -187.65% | 754.96% | -168.74% |